HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Italian experience regarding the prevention of Duchenne and Becker muscular dystrophies.

Abstract
The indirect approach to carrier detection and prenatal diagnosis of Duchenne and Becker muscular dystrophies based on the study of DNA polymorphisms closely linked to this gene has been followed by five Italian laboratories in the study of 106 pedigrees. Out of 354 women studied up to 1 May 1987, 147 were identified as carriers because of pedigree information and/or of increased creatine phosphokinase (CPK) values. Of the remaining 207, 184 could be assigned to three arbitrarily defined risk categories (low, intermediate and high) using linkage analysis. This disaggregation of women at risk is clearly more useful than that defined before DNA analysis, in which the same 184 women could be assigned only to the low or intermediate risk categories. Prenatal diagnosis was theoretically possible in 90% of carrier women, and was actually performed in 14 pregnancies, which led to the identification of four affected male foetuses, one also having Down syndrome.
AuthorsG Romeo, M Devoto, N Archidiacono, A Ferlini, L Roncuzzi, M A Melis, E Paderi, M Ferrari, S Tedeschi, G Galluzzi
JournalEuropean journal of pediatrics (Eur J Pediatr) Vol. 147 Issue 4 Pg. 412-5 (May 1988) ISSN: 0340-6199 [Print] Germany
PMID3165066 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Genetic Markers
  • DNA
  • Creatine Kinase
Topics
  • Chromosome Deletion
  • Creatine Kinase (genetics)
  • DNA (analysis)
  • Female
  • Genetic Carrier Screening
  • Genetic Linkage
  • Genetic Markers
  • Humans
  • Italy
  • Male
  • Muscular Dystrophies (genetics, prevention & control)
  • Mutation
  • Nucleic Acid Hybridization
  • Pedigree
  • Polymorphism, Genetic
  • Prenatal Diagnosis
  • X Chromosome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: